Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10017926HBVENSG00000175899.15protein_codingA2MNoNo2P01023
TVIS10017460HBVENSG00000175899.15protein_codingA2MNoNo2P01023
TVIS10033096HBVENSG00000175899.15protein_codingA2MNoNo2P01023
TVIS10035096HBVENSG00000175899.15protein_codingA2MNoNo2P01023
TVIS10018412HBVENSG00000175899.15protein_codingA2MNoNo2P01023
TVIS10019448HBVENSG00000175899.15protein_codingA2MNoNo2P01023
TVIS10045150HBVENSG00000175899.15protein_codingA2MNoNo2P01023
TVIS30011672HIVENSG00000175899.15protein_codingA2MNoNo2P01023
TVIS30002004HIVENSG00000175899.15protein_codingA2MNoNo2P01023
TVIS30080257HIVENSG00000175899.15protein_codingA2MNoNo2P01023
TCGA Plot Options
Drug Information
GeneA2M
DrugBank IDDB00515
Drug NameCisplatin
Target IDBE0000910
UniProt IDP01023
Regulation Type
PubMed IDs16773208
CitationsKhalaila I, Bergamo A, Bussy F, Sava G, Dyson PJ: The role of cisplatin and NAMI-A plasma-protein interactions in relation to combination therapy. Int J Oncol. 2006 Jul;29(1):261-8.
GroupsApproved
Direct ClassificationTransition metal chlorides
SMILES[H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H]
Pathways
PharmGKBPA449014
ChEMBLCHEMBL11359